Htg Molecular Diagnostics

Developer of diagnostics and targeted therapeutics across a variety of disease areas

placeTucson, Arizona, United States calendar_todayFounded 1997 groups47 employees language htgmolecular.com

Registered entities

Investor mix

13 investors on record; lead investors include Fletcher Spaght, Novo Holdings, SR One, Merck; 1 has since exited.

Investor typeCountShare
Venture capital754%
Accelerator & incubator18%
Other / undisclosed538%
Coming soon